Shivani Gupta, C. W. Devadass, Shubham Varshney, Sml Prakash Babu
{"title":"Histopathological Evaluation and Analysis of Immunohistochemical Markers p53 and CD44S in Renal Cell Carcinoma: A Cross-sectional Study","authors":"Shivani Gupta, C. W. Devadass, Shubham Varshney, Sml Prakash Babu","doi":"10.7860/jcdr/2023/63352.18192","DOIUrl":null,"url":null,"abstract":"Introduction: Renal Cell Carcinoma (RCC) is the 9th and 14th most common cancer in men and women, respectively, and among the most lethal urological cancers. Upto 30% of patients experience recurrence within five years postnephrectomy. Therefore, the predictors of disease survival and molecular markers associated with clinical prognostic parameters should be identified. Aim: To examine the histopathological features of RCC and investigate the association of Tumour protein p53 (p53) and Cluster of Differentiation 44S (CD44S) expression with prognostic factors. Materials and Methods: The present prospective crosssectional study was conducted in the Department of Pathology, M.S Ramaiah Medical College and Hospitals, Bengaluru, Karnataka, India, from June 2017 to May 2019. Radical and partial nephrectomy specimens of RCC patients were obtained for the study. In each case age, tumour histologic type, tumour size, Fuhrman nuclear grade, rhabdoid features, necrosis, tumour stage and p53 and CD44S status were evaluated through immunohistochemistry. The Chi-square test was used to evaluate differences in CD44S and p53 expression among different groups. Data were entered in Microsoft (MS) Excel version 11 and was analysed using International Business Machines Statistical Package for the Social Sciences (IBM SPSS) software version 20.0. Results: The study included 50 RCC patients with a mean age of 56.64 years and male:female ratio was 2.8:1. CD44S and p53 positivity were noted in 33 (66%) and 27 (54%) patients, respectively. Weak, moderate, and strong CD44S expression were observed in 13 (26%), 8 (16%) and 12 (24%) patients, respectively and those of p53 in 9 (18%), 14 (28%) and 13 (26%) patients, respectively. Patients with higher Fuhrman nuclear grades exhibited stronger CD44S (n=24, 85.71%) and p53 (n=19, 67.85%) expression than did those with lower grades. Conclusion: The clear cell carcinoma is the most common histologic subtype. Presence of rhabdoid features and necrosis is seen with advanced Tumour, Nodal and Metastasis (TNM) stage. A significant association between p53 and CD44S immunohistochemical expression and higher Fuhrman nuclear grade suggests increased expression of p53 and CD44S and indicates an aggressive clinical course that can be used as a marker of poor prognosis.","PeriodicalId":15483,"journal":{"name":"JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH","volume":"27 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7860/jcdr/2023/63352.18192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Renal Cell Carcinoma (RCC) is the 9th and 14th most common cancer in men and women, respectively, and among the most lethal urological cancers. Upto 30% of patients experience recurrence within five years postnephrectomy. Therefore, the predictors of disease survival and molecular markers associated with clinical prognostic parameters should be identified. Aim: To examine the histopathological features of RCC and investigate the association of Tumour protein p53 (p53) and Cluster of Differentiation 44S (CD44S) expression with prognostic factors. Materials and Methods: The present prospective crosssectional study was conducted in the Department of Pathology, M.S Ramaiah Medical College and Hospitals, Bengaluru, Karnataka, India, from June 2017 to May 2019. Radical and partial nephrectomy specimens of RCC patients were obtained for the study. In each case age, tumour histologic type, tumour size, Fuhrman nuclear grade, rhabdoid features, necrosis, tumour stage and p53 and CD44S status were evaluated through immunohistochemistry. The Chi-square test was used to evaluate differences in CD44S and p53 expression among different groups. Data were entered in Microsoft (MS) Excel version 11 and was analysed using International Business Machines Statistical Package for the Social Sciences (IBM SPSS) software version 20.0. Results: The study included 50 RCC patients with a mean age of 56.64 years and male:female ratio was 2.8:1. CD44S and p53 positivity were noted in 33 (66%) and 27 (54%) patients, respectively. Weak, moderate, and strong CD44S expression were observed in 13 (26%), 8 (16%) and 12 (24%) patients, respectively and those of p53 in 9 (18%), 14 (28%) and 13 (26%) patients, respectively. Patients with higher Fuhrman nuclear grades exhibited stronger CD44S (n=24, 85.71%) and p53 (n=19, 67.85%) expression than did those with lower grades. Conclusion: The clear cell carcinoma is the most common histologic subtype. Presence of rhabdoid features and necrosis is seen with advanced Tumour, Nodal and Metastasis (TNM) stage. A significant association between p53 and CD44S immunohistochemical expression and higher Fuhrman nuclear grade suggests increased expression of p53 and CD44S and indicates an aggressive clinical course that can be used as a marker of poor prognosis.
导读:肾细胞癌(RCC)在男性和女性中分别是第9位和第14位最常见的癌症,也是最致命的泌尿系统癌症之一。高达30%的患者在肾切除术后5年内复发。因此,应该确定疾病生存的预测因子和与临床预后参数相关的分子标记。目的:探讨肿瘤蛋白p53 (p53)和分化簇44S (CD44S)表达与肾细胞癌预后的关系。材料与方法:本前瞻性横断面研究于2017年6月至2019年5月在印度卡纳塔克邦班加罗尔M.S Ramaiah医学院和医院病理科进行。本研究收集了肾细胞癌患者的全部和部分肾切除术标本。通过免疫组织化学方法对每例患者的年龄、肿瘤组织学类型、肿瘤大小、Fuhrman核分级、横纹肌特征、坏死、肿瘤分期及p53和CD44S状态进行评估。采用卡方检验评价CD44S、p53在不同组间的表达差异。数据在Microsoft (MS) Excel version 11中输入,并使用International Business Machines Statistical Package for the Social Sciences (IBM SPSS) version 20.0软件进行分析。结果:纳入RCC患者50例,平均年龄56.64岁,男女比例为2.8:1。CD44S阳性33例(66%),p53阳性27例(54%)。CD44S弱、中、强表达分别为13例(26%)、8例(16%)、12例(24%),p53表达分别为9例(18%)、14例(28%)、13例(26%)。Fuhrman核分级高的患者CD44S (n=24, 85.71%)和p53 (n=19, 67.85%)表达较低。结论:透明细胞癌是最常见的组织学亚型。在肿瘤、淋巴结和转移(TNM)晚期出现横纹肌样特征和坏死。p53和CD44S免疫组织化学表达与更高的Fuhrman核分级之间的显著关联表明p53和CD44S表达增加,表明临床病程具有侵袭性,可作为预后不良的标志。